{"id":131754,"date":"2022-07-28T02:57:09","date_gmt":"2022-07-28T06:57:09","guid":{"rendered":"https:\/\/44.250.171.167\/?p=131754"},"modified":"2022-10-06T04:30:50","modified_gmt":"2022-10-06T08:30:50","slug":"infographic-biocon-opens-this-year-with-a-stellar-performance-reporting-71-growth-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/infographic-biocon-opens-this-year-with-a-stellar-performance-reporting-71-growth-in-profits\/","title":{"rendered":"Infographic: Biocon opens this year with a stellar performance reporting 71% growth in profits"},"content":{"rendered":"\n

Biocon on Wednesday reported 71% year-on-year (YoY) jump in net profit to Rs 144 crore during Q1FY23, driven by sales of biosimilar insulin glargine in the US, despite rise in research & development expenses. The drug maker reported Rs 84 crore net profit in the corresponding period of previous year. Total revenues rose 23% YoY to Rs 2,217 crore in Q1FY23, compared to Rs 1,808 in Q1FY22.<\/p>\n\n\n\n

The earnings before interest, tax, depreciation and amortization (EBITDA) grew 9% YoY to Rs 478 crore in Q1FY23 and EBITDA margins dropped 200 basis points to 22%. Biocon Biologics share which constitutes 45% of revenues reported 29% YoY growth to Rs Rs 977 crore in Q1FY23, while the generic business rose 19% to Rs 580 Cr.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Dr Arun Chandavarkar, managing director of Biocon Biologics said the company has initiated global clinical trials for two monoclonal antibodies and advanced its other pipeline assets which led to a 120% increase in R&D investments this quarter.<\/p>\n\n\n\n

“Whilst this impacts EBITDA in the near term, such investments will create a strong portfolio to secure our future growth,” Chandravarkar said.<\/p>\n\n\n\n

\u201cOur strategic alliance with Serum Institute Life Sciences for vaccines and the acquisition of Viatris\u2019 global biosimilars business are on track for closure in the second half of this calendar year,\u201d he added.<\/p>\n","protected":false},"excerpt":{"rendered":"

Biocon on Wednesday reported 71% year-on-year (YoY) jump in net profit to Rs 144 crore during Q1FY23, driven by sales of biosimilar insulin glargine in the US, despite rise in research & development expenses. The drug maker reported Rs 84 crore net profit in the corresponding period of previous year. Total revenues rose 23% YoY […]<\/p>\n","protected":false},"author":1863,"featured_media":49407,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5],"tags":[10155,10156],"class_list":["post-131754","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-latest","tag-biosimilars","tag-novel-drugs"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":131710,"url":"https:\/\/alphastreet.com\/india\/infographic-tata-steel-q1fy23-profit-falls-12-8-to-rs-7765-cr-while-revenue-up-18-6\/","url_meta":{"origin":131754,"position":0},"title":"Infographic: Tata Steel Q1FY23- Profit falls 12.8% to Rs 7,765 Cr, while Revenue up 18.6%","author":"Chirag Gupta","date":"July 26, 2022","format":false,"excerpt":"Tata Steel reported a consolidated net profit (attributable to the owners of the company) at Rs 7,765 crore for the quarter ended June, down 12.8 per cent over the year-ago period, in what the company described as a \u201cchallenging\u201d quarter. Sequentially, net profit was down 20.4 per cent. Revenue from\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"trending stocks high volatility","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":141647,"url":"https:\/\/alphastreet.com\/india\/biocon-ltd-nse-biocon-ltd-q3-fy23-results-out-total-income-rise-35-yoy\/","url_meta":{"origin":131754,"position":1},"title":"Biocon ltd.(NSE: BIOCON) Ltd. : Q3 FY23 Results Out; Total Income rise 35% YoY","author":"Divyansh_Kasana","date":"February 14, 2023","format":false,"excerpt":"Biocon Limited (NSE:BIOCON) is an Indian multinational biopharmaceutical company based in Bangalore, India. The company was founded in 1978 by Kiran Mazumdar-Shaw and is now one of the largest biopharmaceutical companies in India. Biocon is primarily engaged in the production of biosimilars, generic biologics, and research-based pharmaceuticals. It also has\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":132751,"url":"https:\/\/alphastreet.com\/india\/hindalco-industries-limited-q1fy23-net-profit-at-all-time-high-of-rs-4119-crore\/","url_meta":{"origin":131754,"position":2},"title":"Hindalco Industries Limited Q1FY23; Net Profit at all-time high of Rs.4,119 crore","author":"Hardik Bhandare","date":"August 10, 2022","format":false,"excerpt":"In Q1 FY23, Hindalco Industries Limited (NSE: HINDALCO) again reported its highest net profit, topping its previous high mark in Q4 FY22. The company's consolidated PAT reached a record high of Rs. 4,119 crore, up 48% year over year. First-quarter total revenue increased 40% year over year to Rs 58,018\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/08\/0ee64d0c-5d1f-406b-a947-29f24361dde9-scaled.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/08\/0ee64d0c-5d1f-406b-a947-29f24361dde9-scaled.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/08\/0ee64d0c-5d1f-406b-a947-29f24361dde9-scaled.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/08\/0ee64d0c-5d1f-406b-a947-29f24361dde9-scaled.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/08\/0ee64d0c-5d1f-406b-a947-29f24361dde9-scaled.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/08\/0ee64d0c-5d1f-406b-a947-29f24361dde9-scaled.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":132596,"url":"https:\/\/alphastreet.com\/india\/infographic-sbi-q1-net-profit-falls-by-6-7-on-standalone-basis-due-to-loss-in-treasury\/","url_meta":{"origin":131754,"position":3},"title":"Infographic: SBI Q1, Net profit falls by 6.7% on standalone basis due to loss in treasury","author":"Chirag Gupta","date":"August 8, 2022","format":false,"excerpt":"On Saturday State Bank of India reported a 1 per cent year-on-year (YoY) drop in net profit at Rs 7,325 crore compared with Rs 7,380 crore in the same quarter last year on a consolidated basis. Net interest income (NII) for the quarter rose 12.87 per cent YoY to Rs\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"trending stocks high volatility","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":133059,"url":"https:\/\/alphastreet.com\/india\/infographic-grasim-industries-delivers-stellar-performance-in-q1fy23-revenue-up-by-41\/","url_meta":{"origin":131754,"position":4},"title":"Infographic: Grasim Industries delivers stellar performance in Q1FY23, Revenue up by 41%","author":"Chirag Gupta","date":"August 12, 2022","format":false,"excerpt":"On Friday, Aditya Birla Group firm Grasim Industries Ltd reported a 12.7 per cent increase in consolidated net profit at Rs 2,758.75 crore for the quarter ended June 30, 2022. The company had posted a net profit of Rs 2,447.97 crore for April-June 2021-22, Grasim Industries said in a regulatory\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"trending stocks high volatility","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":154398,"url":"https:\/\/alphastreet.com\/india\/garware-hi-tech-films-ltd-reports-resilient-q1fy24-performance-driven-by-specialized-films-growth\/","url_meta":{"origin":131754,"position":5},"title":"Garware Hi-Tech Films Ltd. Reports Resilient Q1FY24 Performance Driven by Specialized Films Growth","author":"Divyansh_Kasana","date":"August 21, 2023","format":false,"excerpt":"Company Description: Garware Hi-Tech Films Ltd., a key player in the Containers & Packaging sector, has showcased resilience and growth in its Q1FY24 results. With a focus on specialized films, the company maintains a commitment to financial prudence and operational excellence. Financial Highlights: - Revenue: The company reported a consolidated\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/131754","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=131754"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/131754\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/49407"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=131754"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=131754"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=131754"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}